Sage Therapeutics Stock Jumps on Biogen's Surprising Acquisition Offer
Bill McColl
Bill McColl 1 year ago
Senior Contributor & Veteran Media Producer #Markets News
0
8.0K

Sage Therapeutics Stock Jumps on Biogen's Surprising Acquisition Offer

Biogen has made an unexpected bid to acquire all remaining shares of Sage Therapeutics, sparking a significant surge in Sage's stock price.

Bill McColl brings over 25 years of expertise as a senior producer and writer across TV, radio, and digital platforms, leading teams in delivering impactful news coverage on major global events.

Highlights

  • Biogen has extended an unsolicited offer to purchase all outstanding shares of Sage Therapeutics it does not currently own.
  • The proposed acquisition price of $7.22 per share represents a 30% premium over Sage's last closing price.
  • Biogen currently holds a 10.2% ownership stake in Sage Therapeutics.

Shares of Sage Therapeutics (SAGE) surged nearly 40% following news that Biogen (BIIB) proposed to acquire the remaining shares at $7.22 each.

This non-binding, unsolicited offer exceeds Sage’s previous closing price of $5.55 by a substantial margin.

The Sage board has announced it will thoroughly assess Biogen's proposal to determine the best strategy for the company and its shareholders.

Biogen's Existing Stake in Sage

Regulatory filings reveal Biogen owns approximately 6.24 million shares, equating to a 10.2% stake in Sage Therapeutics.

The offer coincides with both companies preparing presentations for the upcoming J.P. Morgan Healthcare Conference in San Francisco.

Despite today's strong rally, Sage's stock has declined nearly 75% over the past year, while Biogen's shares showed a slight dip of under 1% in early trading.

Sage Therapeutics Stock Chart
Source: TradingView

If you have valuable news tips for our reporters, please contact us at tips@investopedia.com.

Discover engaging topics and analytical content in Markets News as of 24-02-2024. The article titled " Sage Therapeutics Stock Jumps on Biogen's Surprising Acquisition Offer " provides new insights and practical guidance in the Markets News field. Each topic is meticulously analyzed to deliver actionable information to readers.

The topic " Sage Therapeutics Stock Jumps on Biogen's Surprising Acquisition Offer " helps you make smarter decisions within the Markets News category. All topics on our website are unique and offer valuable content for our audience.

0
8.0K

InLiber is a global news platform delivering fast, accurate, and trustworthy information from around the world.

We cover breaking news and insights across technology, politics, health, sports, culture, finance, and more. Designed for all internet users, InLiber provides a user-friendly interface, verified sources, and in-depth coverage to keep you informed in the digital age.